Professor Olivia Wu

  • Professor in Health Technology Assessment (Health Economics and Health Technology Assessment)
  • Associate (School of Medicine)

telephone: 01413303296
email: Olivia.Wu@glasgow.ac.uk

Research interests

Olivia is the Deputy Director of the HEHTA Research Unit, where she also leads the Evidence Synthesis Research Programme. She has a BSc(Hons) in Pharmacy, MSc in Clinical Pharmacology and PhD in Public Health and Health Economics.

Olivia's research interest in health technology assessment methodologies focuses on the areas of evidence synthesis (including systematic review and meta-analysis of aggregate and individual patient data; direct, indirect and networked evidence), risk prediction modelling and economic evaluation. She has undertaken research in a variety of clinical areas including cardiovascular disease, haematology, obstetrics and gynaecology, and rheumatology.

In addition to her research, Olivia serves as members of Technology Appraisal Committee for the National Institute for Health and Care Excellence (NICE) and the Health Service and Population Health Research Committee for the Chief Scientist Office (CSO) Scotland. She is also health economics advisor to the Scottish Intercollegiate Guidelines Network (SIGN).

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Web-based Physiotherapy for people with Multiple Sclerosis (WEB-PaMS)
    Multiple Sclerosis Society
    2015 - 2016
     
  • Estimating Cost Effectiveness for Screening Strategies for Hepatitis B, C and HIV Infection in different populations in Europe
    European Centre for Disease Prevention and Control
    2015 - 2015
     
  • Individual interventions after testing for HIV to reduce risky sexual behaviour in men who have sex with men (MSM): A mixed method systematic review
    National Institute for Health Research
    2014 - 2015
     
  • Selling Scottish Stroke Services in an International Context
    Chest, Heart & Stroke, Scotland
    2014 - 2015
     
  • A very early rehabilitation trial after stroke (AVERT): A phase 3, multicentre, randomised controlled trial
    National Institute for Health Research
    2013 - 2016
     
  • Health Economics Assessment of GOLD acute Stroke Technology
    Scottish Executive Health Department
    2013 - 2013
     
  • Cancer and Venous Access (CAVA) - a three way randomised controlled trial of long-term venous access devices for the delivery of chemotherapy.
    National Institute for Health Research
    2013 - 2018
     
  • Cancer and Venous Access (CAVA) - a three way randomised controlled trial of long-term venous access devices for the delivery of chemotherapy.
    National Institute for Health Research
    2013 - 2018
     
  • Costs and complications of diabetes - investigation in a comprehensive national diabetes register
    Medical Research Council
    2012 - 2015
     
  • Randomised controlled trial on the efficacy and mechanism of action of gabapentin for the management of chronic pelvic pain in women
    Scottish Executive Health Department
    2012 - 2014
     
  • Estimating Cost Effectiveness for Screening Strategies for Hepatitis B, C and HIV Infection in different populations in Europe
    European Centre for Disease Prevention and Control
    2011 - 2013
     
  • A prospective randomised trial of myomectomy versus uterine artery embolisation (UAE) for women with uterine fibroids who wish to retain or improve their fertility (FEMME)
    National Institute for Health Research
    2011 - 2018
     
  • Port-a-cath and Hickman line devices for chemotherapy delivery: a feasibility study to measure clinical outcomes and health economic data prior to a randomised controlled trial.
    Scottish Executive Health Department
    2011 - 2013
     
  • Economic impact of occupational health case managers.
    NHS Tayside
    2010 - 2010
     
  • Economic impact of occupational health case managers.
    Occupational Health and Safety Executive
    2010 - 2010
     
  • A Very Early Rehabilitation Trial (AVERT) UK
    Stroke Association
    2010 - 2012
     
  • Implementation of complex interventions in stroke
    Stroke Association
    2009 - 2012
     
  • A multi-centre randomised controlled trial of very early mobilisation after stroke (AVERT) in Scotland
    Scottish Government Health Directorates
    2009 - 2010
     
  • A multi-centre randomised controlled trial of very early mobilisation after stroke (AVERT) in Scotland
    Chest, Heart & Stroke, Scotland
    2008 - 2010
     
  • Stock-take of guidance and audit relating to venous thrombosis prevention & treatment in NHS Scotland
    NHS Quality Improvement Scotland
    2008 - 2009
     
  • Health Economics and Disease Registries
    University of Massachusetts Medical School
    2008 - 2010
     
  • Long term (3-5 years) follow up and MRI imaging of the REST cohort trial
    Scottish Executive Health Department
    2007 - 2009
     
  • Health Economics and Disease Registries
    University of Massachusetts Medical School
    2006 - 2008
     

Publications

List by: Type | Date

Jump to: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004
Number of items: 54.

2014

McPherson, K., Manyonda, I., Lumsden, M.-A., Belli, A.-M., Moss, J., Wu, O., Middleton, L., and Daniels, J. (2014) A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial. Trials, 15(1), p. 468. (doi:10.1186/1745-6215-15-468)

Iliodromiti, S., Kelsey, T. W., Wu, O., Anderson, R. A., and Nelson, S. M. (2014) The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Human Reproduction Update, 20(4), pp. 560-570. (doi:10.1093/humupd/dmu003)

Kulkarni, S., Wu, O., Kasthuri, R., and Moss, J.G. (2014) Centrally inserted external catheters and totally implantable ports for the delivery of chemotherapy: a systematic review and meta-analysis of device-related complications. CardioVascular and Interventional Radiology, 37(4), pp. 990-1008. (doi:10.1007/s00270-013-0771-3)

Ponomarev, D., Miller, C., Govan, L., Haig, C., Wu, O., and Langhorne, P. (2014) Complications following incident stroke resulting in readmissions: an analysis of data from three Scottish health surveys. International Journal of Stroke, (doi:10.1111/ijs.12191) (Early Online Publication)

2013

Palmateer, N.E., Hutchinson, S.A., Innes, H., Schnier, C., Wu, O., Goldberg, D.J., and Hickman, M. (2013) Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. International Journal of Drug Policy, 24(2), pp. 85-100. (doi:10.1016/j.drugpo.2012.08.006)

Craig, L.E., Wu, O., Bernhardt, J., and Langhorne, P. (2013) Approaches to economic evaluations of stroke rehabilitation. International Journal of Stroke, 9(1), pp. 88-100. (doi:10.1111/ijs.12041)

2012

Wu, O., Briggs, A., and MacIntyre, K. (2012) Mobile phone use for contacting emergency services in life-threatening circumstances. Journal of Emergency Medicine, 42(3), pp. 291-298. (doi:10.1016/j.jemermed.2011.02.022)

Govan, L. et al. (2012) The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia, 55(9), pp. 2356-2360. (doi:10.1007/s00125-012-2601-6)

Horne, A.W., Critchley, H.O.D., Doust, A., Fehr, D., Wilson, J., Wu, O., Jack, S., Porter, M., Lewis, S., and Bhattacharya, S. (2012) GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol. BMJ Open, 2(3), e001297. (doi:10.1136/bmjopen-2012-001297)

Horne, A.W., Critchley, H.O.D., Doust, A., Fehr, D., Wilson, J., Wu, O., Jack, S., Porter, M., Lewis, S., and Bhattacharya, S. (2012) GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin of the management of chronic pelvic pain in women: study protocol. BMJ Open, 2(3), e001297. (doi:10.1136/bmjopen-2012-001297)

Westaby, D.T., Wu, O., Duncan, W., Critchley, H.O.D., Tong, S., and Horne, A.W. (2012) Has increased clinical experience with methotrexate reduced the direct costs of medical management of ectopic pregnancy compared to surgery? BMC Pregnancy and Childbirth, 12(98), (doi:10.1186/1471-2393-12-98)

2011

Govan, L. et al. (2011) Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care, 34(9), pp. 1992-1997. (doi:10.2337/dc10-2099)

Craig, L.E., Wu, O., Bernhardt, J., and Langhorne, P. (2011) Predictors of poststroke mobility: systematic review. International Journal of Stroke, 6(4), pp. 321-327. (doi:10.1111/j.1747-4949.2011.00621.x)

Clarke, P., and Wu, O. (2011) ABO blood groups and thrombosis: a causal association, but is there value in screening? Future Cardiology, 7(2), pp. 191-201. (doi:10.2217/fca.10.191)

Craig, L.E., Wu, O., Gilmour, H., Barber, M., and Langhorne, P. (2011) Developing and validating a predictive model for stroke progression. Cerebrovascular Diseases, 1(1), pp. 105-114. (doi:10.1159/000334473)

Govan, L. et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 54(8), pp. 2000-2008. (doi:10.1007/s00125-011-2176-7)

Moss, J.G., Cooper, K.G., Khaund, A., Murray, L., Murray, G.D., Wu, O., Craig, L.E., and Lumsden, M.A. (2011) Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG: An International Journal of Obstetrics and Gynaecology, 118(8), pp. 936-944. (doi:10.1111/j.1471-0528.2011.02952.x)

Wellwood, I., Wu, O., Langhorne, P., McKevitt, C., Di Carlo, A., Rudd, A.G., and Wolfe, C.D.A. (2011) Developing a tool to assess quality of stroke care across European populations: The EROS quality assessment tool. Stroke, 42(5), pp. 1207-1211. (doi:10.1161/STROKEAHA.110.598938)

2010

Adachi, J. D. et al. (2010) Impact of Prevalent Fractures on Quality of Life: Baseline Results From the Global Longitudinal Study of Osteoporosis in Women. Mayo Clinic Proceedings, 85(9), pp. 806-813. (doi:10.4065/mcp.2010.0082)

Alcorn, N., Tierney, A., Wu, O., Gilmour, H., and Madhok, R. (2010) Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(8), p. 1571. (doi:10.1136/ard.2009.122424)

Clark, P., Wu, O., Greer, I.A., and Lowe, G.D.O. (2010) Venous thrombosis prevention more than just guidelines. British Journal of Haematology, 149(1), pp. 50-54. (doi:10.1111/j.1365-2141.2010.08080.x)

Craig, L., Bernhardt, J., Langhorne, P., and Wu, O. (2010) Early mobilization after stroke: an example of an individual patient data meta-analysis of a complex intervention. Stroke, 41(11), pp. 2632-2636. (doi:10.1161/STROKEAHA.110.588244)

2009

Wu, O., Levy, A.R., Briggs, A., Lewis, G., and Jardine, A. (2009) Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation, 87(9), pp. 1330-1339. (doi:10.1097/TP.0b013e3181a236e0)

Briggs, A., Starkie, H., and Wu, O. (2009) Health economics in asthma and COPD. In: Barnes, P.J., Drazen, J.M., Rennard, S.I. and Thomson, N.C. (eds.) Asthma and COPD. Academic Press/Elsevier: London, pp. 751-760. ISBN 9780123740014

Craig, L.E., Langhorne, P., Wu, O., Walters, M.R., Ritchie, C.K., and Smith, L.N. (2009) AVERT Scotland: introducing a very early rehabilitation trial (AVERT) to Scotland [POSTER]. Cerebrovascular Diseases, 27(suppl.), p. 241. (doi:10.1159/000221782)

Kerr, G., Ray, G., Stott, D., Wu, O., and Langhorne, P. (2009) Elevated Troponin after Stroke: A Systematic Review. Cerebrovascular Diseases, 28(3), pp. 220-226. (doi:10.1159/000226773 )

Wu, O. (2009) Oral contraceptives and venous thromboembolism: identifying the safest option. Expert Reviews, 7(12), pp. 1513-1516. (doi:10.1586/erc.09.151)

2008

Hirst, A., Dutton, S., Wu, O., Briggs, A., Edwards, C., Waldenmaier, L., Maresh, M., Nicholson, A., and McPherson, K. (2008) A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids: the HOPEFUL study. Health Technology Assessment, 12(5),

Clark, P., Walker, I.D., Govan, L., Wu, O., and Greer, I.A. (2008) The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. British Journal of Haematology, 140(2), pp. 236-240. (doi:10.1111/j.1365-2141.2007.06902.x)

Wu, O., Bayoumi, N., Vickers, M., and Clark, P. (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 6(1), pp. 62-69. (doi:10.1111/j.1538-7836.2007.02818.x)

Wu, O., Bayoumi, N., Vickers, M. A., and Clark, P. (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 6(1), pp. 62-69. (doi:10.1111/j.1538-7836.2007.02818.x)

Clark, P., and Wu, O. (2008) ABO(H) blood groups and pre-eclampsia - A systematic review and meta-analysis. Thrombosis and Haemostasis, 100(3), pp. 469-474.

Hirst, A., Dutton, S., Wu, O., Briggs, A., Edwards, C., Waldenmaier, L., Maresh, M., Nicholson, A., and McPherson, K. (2008) The HOPEFUL Study: a multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation (UAE) for the treatment of symptomatic uterine fibroids. Health Technology Assessment, 123(5), pp. 1-248.

2007

Wu, O., Briggs, A.H., Dutton, S., Hirst, A., Maresh, M., Nicholson, A., and McPherson, K. (2007) Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study. BJOG: An International Journal of Obstetrics and Gynaecology, 114(11), pp. 1352-1362. (doi:10.1111/j.1471-0528.2007.01525.x)

Wu, O., and Greer, I.A. (2007) Is screening for thrombophilia cost-effective? Current Opinion in Hematology, 14(5), pp. 500-503. (doi:10.1097/MOH.0b013e32825f5318)

Edwards, R.D., Moss, J.G., Lumsden, M.A., Wu, O., Murray, L.S., Twaddle, S., and Murray, G.D. (2007) Uterine-artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine, 356(4), pp. 360-370.

Madhok, R., and Wu, O. (2007) Systemic lupus erythematosus. American Family Physician, 76(9), pp. 1351-1353.

Wu, O., and Greer, I. (2007) Is screening for thrombophilia cost-effective? Current Opinion in Hematology, 14, pp. 500-503.

2006

Madhok, R., Wu, O., McKellar, G., and Singh, G. (2006) Non-steroidal anti-inflammatory drugs—changes in prescribing may be warranted. Rheumatology, 45(12), pp. 1458-1460. (doi:10.1093/rheumatology/kel353)

Wu, O., and Langhorne, P. (2006) The challenge of acute-stroke management: does telemedicine offer a solution? International Journal of Stroke, 1(4), pp. 201-207. (doi:10.1111/j.1747-4949.2006.00062.x)

Wu, O., and Greer, I.A. (2006) More on 'universal' versus 'selected' screening for thrombophilia: the hidden costs of false-positive diagnosis - response to Favaloro and Keeling. British Journal of Haematology, 134(2), p. 241. (doi:10.1111/j.1365-2141.2006.06139.x)

Robertson, L. et al. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132(2), pp. 171-196. (doi:10.1111/j.1365-2141.2005.05847.x)

Singh, G., Wu, O., Langhorne, P., and Madhok, R. (2006) Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Research and Therapy, 8, R153. (doi:10.1186/ar2047)

Wu, O. et al. (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technology Assessment, 10, 1-+.

Zatarain, E., Wu, O., and Singh, G. (2006) Non-steroidal anti-inflammatory drugs-COX-2 inhibition. In: Capell, H., Luthra, H.S. and Madhok, R. (eds.) The year in rheumatic disorders. Clinical Publishing: Oxford. ISBN 9786610309962

2005

Wu, O. et al. (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thrombosis and Haemostasis, 94, pp. 17-25.

Wu, O. et al. (2005) Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. British Journal of Haematology, 131, pp. 80-90. (doi:10.1111/j.1365-2141.2005.05715.x)

Wu, O. (2005) Postmenopausal hormone replacement therapy and venous thromboembolism. Gender Medicine, 2(Supple), S18-S27. (doi:10.1016/S1550-8579(05)80061-0 )

Wu, O., Clark, P., Lowe, G.D.O., Walker, I.D., and Greer, I.A. (2005) Thrombophilia and venous thromboembolism after total hip or knee replacement surgery: a systematic review. Journal of Thrombosis and Haemostasis, 3(4), pp. 811-813. (doi:10.1111/j.1538-7836.2005.01264.x)

Wu, O. et al. (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombosis and Haemostasis, 94(1), pp. 17-25. (doi:10.1160/TH04-11-0759)

2004

Robertson, L., Wu, O., and Greer, I. (2004) Thrombophilia and adverse pregnancy outcome. Current Opinion in Obstetrics and Gynecology, 16(6), pp. 453-458.

Norman, J., Wu, O., Twaddle, S., Macmillan, S., McMillan, L., Templeton, A., McKenzie, H., Noone, A., Allardyce, G., and Reid, M. (2004) An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK. BJOG: An International Journal of Obstetrics and Gynaecology, 111(11), pp. 1261-1268. (doi:10.1111/j.1471-0528.2004.00324.x)

Wu, O., Knill-Jones, R., Wilson, P., and Craig, N. (2004) The impact of economic information on medical decision making in primary care. Journal of Evaluation in Clinical Practice, 10(3), pp. 407-411. (doi:10.1111/j.1365-2753.2004.00490.x)

Norman, J., Wu, O., Twaddle, S., Macmillan, S., McMillan, L., Templeton, A., McKenzie, H., Noone, A., Allardice, G., and Reid, M. (2004) An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK. BJOG: An International Journal of Obstetrics and Gynaecology, 111(11), pp. 1261-1268. (doi:10.1111/j.1471-0528.2004.00324.x)

This list was generated on Thu Mar 26 13:05:01 2015 GMT.
Number of items: 54.

Articles

McPherson, K., Manyonda, I., Lumsden, M.-A., Belli, A.-M., Moss, J., Wu, O., Middleton, L., and Daniels, J. (2014) A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial. Trials, 15(1), p. 468. (doi:10.1186/1745-6215-15-468)

Iliodromiti, S., Kelsey, T. W., Wu, O., Anderson, R. A., and Nelson, S. M. (2014) The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Human Reproduction Update, 20(4), pp. 560-570. (doi:10.1093/humupd/dmu003)

Kulkarni, S., Wu, O., Kasthuri, R., and Moss, J.G. (2014) Centrally inserted external catheters and totally implantable ports for the delivery of chemotherapy: a systematic review and meta-analysis of device-related complications. CardioVascular and Interventional Radiology, 37(4), pp. 990-1008. (doi:10.1007/s00270-013-0771-3)

Ponomarev, D., Miller, C., Govan, L., Haig, C., Wu, O., and Langhorne, P. (2014) Complications following incident stroke resulting in readmissions: an analysis of data from three Scottish health surveys. International Journal of Stroke, (doi:10.1111/ijs.12191) (Early Online Publication)

Palmateer, N.E., Hutchinson, S.A., Innes, H., Schnier, C., Wu, O., Goldberg, D.J., and Hickman, M. (2013) Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. International Journal of Drug Policy, 24(2), pp. 85-100. (doi:10.1016/j.drugpo.2012.08.006)

Craig, L.E., Wu, O., Bernhardt, J., and Langhorne, P. (2013) Approaches to economic evaluations of stroke rehabilitation. International Journal of Stroke, 9(1), pp. 88-100. (doi:10.1111/ijs.12041)

Wu, O., Briggs, A., and MacIntyre, K. (2012) Mobile phone use for contacting emergency services in life-threatening circumstances. Journal of Emergency Medicine, 42(3), pp. 291-298. (doi:10.1016/j.jemermed.2011.02.022)

Govan, L. et al. (2012) The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia, 55(9), pp. 2356-2360. (doi:10.1007/s00125-012-2601-6)

Horne, A.W., Critchley, H.O.D., Doust, A., Fehr, D., Wilson, J., Wu, O., Jack, S., Porter, M., Lewis, S., and Bhattacharya, S. (2012) GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol. BMJ Open, 2(3), e001297. (doi:10.1136/bmjopen-2012-001297)

Horne, A.W., Critchley, H.O.D., Doust, A., Fehr, D., Wilson, J., Wu, O., Jack, S., Porter, M., Lewis, S., and Bhattacharya, S. (2012) GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin of the management of chronic pelvic pain in women: study protocol. BMJ Open, 2(3), e001297. (doi:10.1136/bmjopen-2012-001297)

Westaby, D.T., Wu, O., Duncan, W., Critchley, H.O.D., Tong, S., and Horne, A.W. (2012) Has increased clinical experience with methotrexate reduced the direct costs of medical management of ectopic pregnancy compared to surgery? BMC Pregnancy and Childbirth, 12(98), (doi:10.1186/1471-2393-12-98)

Govan, L. et al. (2011) Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care, 34(9), pp. 1992-1997. (doi:10.2337/dc10-2099)

Craig, L.E., Wu, O., Bernhardt, J., and Langhorne, P. (2011) Predictors of poststroke mobility: systematic review. International Journal of Stroke, 6(4), pp. 321-327. (doi:10.1111/j.1747-4949.2011.00621.x)

Clarke, P., and Wu, O. (2011) ABO blood groups and thrombosis: a causal association, but is there value in screening? Future Cardiology, 7(2), pp. 191-201. (doi:10.2217/fca.10.191)

Craig, L.E., Wu, O., Gilmour, H., Barber, M., and Langhorne, P. (2011) Developing and validating a predictive model for stroke progression. Cerebrovascular Diseases, 1(1), pp. 105-114. (doi:10.1159/000334473)

Govan, L. et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 54(8), pp. 2000-2008. (doi:10.1007/s00125-011-2176-7)

Moss, J.G., Cooper, K.G., Khaund, A., Murray, L., Murray, G.D., Wu, O., Craig, L.E., and Lumsden, M.A. (2011) Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG: An International Journal of Obstetrics and Gynaecology, 118(8), pp. 936-944. (doi:10.1111/j.1471-0528.2011.02952.x)

Wellwood, I., Wu, O., Langhorne, P., McKevitt, C., Di Carlo, A., Rudd, A.G., and Wolfe, C.D.A. (2011) Developing a tool to assess quality of stroke care across European populations: The EROS quality assessment tool. Stroke, 42(5), pp. 1207-1211. (doi:10.1161/STROKEAHA.110.598938)

Adachi, J. D. et al. (2010) Impact of Prevalent Fractures on Quality of Life: Baseline Results From the Global Longitudinal Study of Osteoporosis in Women. Mayo Clinic Proceedings, 85(9), pp. 806-813. (doi:10.4065/mcp.2010.0082)

Alcorn, N., Tierney, A., Wu, O., Gilmour, H., and Madhok, R. (2010) Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(8), p. 1571. (doi:10.1136/ard.2009.122424)

Clark, P., Wu, O., Greer, I.A., and Lowe, G.D.O. (2010) Venous thrombosis prevention more than just guidelines. British Journal of Haematology, 149(1), pp. 50-54. (doi:10.1111/j.1365-2141.2010.08080.x)

Craig, L., Bernhardt, J., Langhorne, P., and Wu, O. (2010) Early mobilization after stroke: an example of an individual patient data meta-analysis of a complex intervention. Stroke, 41(11), pp. 2632-2636. (doi:10.1161/STROKEAHA.110.588244)

Wu, O., Levy, A.R., Briggs, A., Lewis, G., and Jardine, A. (2009) Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation, 87(9), pp. 1330-1339. (doi:10.1097/TP.0b013e3181a236e0)

Craig, L.E., Langhorne, P., Wu, O., Walters, M.R., Ritchie, C.K., and Smith, L.N. (2009) AVERT Scotland: introducing a very early rehabilitation trial (AVERT) to Scotland [POSTER]. Cerebrovascular Diseases, 27(suppl.), p. 241. (doi:10.1159/000221782)

Kerr, G., Ray, G., Stott, D., Wu, O., and Langhorne, P. (2009) Elevated Troponin after Stroke: A Systematic Review. Cerebrovascular Diseases, 28(3), pp. 220-226. (doi:10.1159/000226773 )

Wu, O. (2009) Oral contraceptives and venous thromboembolism: identifying the safest option. Expert Reviews, 7(12), pp. 1513-1516. (doi:10.1586/erc.09.151)

Hirst, A., Dutton, S., Wu, O., Briggs, A., Edwards, C., Waldenmaier, L., Maresh, M., Nicholson, A., and McPherson, K. (2008) A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids: the HOPEFUL study. Health Technology Assessment, 12(5),

Clark, P., Walker, I.D., Govan, L., Wu, O., and Greer, I.A. (2008) The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. British Journal of Haematology, 140(2), pp. 236-240. (doi:10.1111/j.1365-2141.2007.06902.x)

Wu, O., Bayoumi, N., Vickers, M., and Clark, P. (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 6(1), pp. 62-69. (doi:10.1111/j.1538-7836.2007.02818.x)

Wu, O., Bayoumi, N., Vickers, M. A., and Clark, P. (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 6(1), pp. 62-69. (doi:10.1111/j.1538-7836.2007.02818.x)

Clark, P., and Wu, O. (2008) ABO(H) blood groups and pre-eclampsia - A systematic review and meta-analysis. Thrombosis and Haemostasis, 100(3), pp. 469-474.

Hirst, A., Dutton, S., Wu, O., Briggs, A., Edwards, C., Waldenmaier, L., Maresh, M., Nicholson, A., and McPherson, K. (2008) The HOPEFUL Study: a multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation (UAE) for the treatment of symptomatic uterine fibroids. Health Technology Assessment, 123(5), pp. 1-248.

Wu, O., Briggs, A.H., Dutton, S., Hirst, A., Maresh, M., Nicholson, A., and McPherson, K. (2007) Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study. BJOG: An International Journal of Obstetrics and Gynaecology, 114(11), pp. 1352-1362. (doi:10.1111/j.1471-0528.2007.01525.x)

Wu, O., and Greer, I.A. (2007) Is screening for thrombophilia cost-effective? Current Opinion in Hematology, 14(5), pp. 500-503. (doi:10.1097/MOH.0b013e32825f5318)

Edwards, R.D., Moss, J.G., Lumsden, M.A., Wu, O., Murray, L.S., Twaddle, S., and Murray, G.D. (2007) Uterine-artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine, 356(4), pp. 360-370.

Madhok, R., and Wu, O. (2007) Systemic lupus erythematosus. American Family Physician, 76(9), pp. 1351-1353.

Wu, O., and Greer, I. (2007) Is screening for thrombophilia cost-effective? Current Opinion in Hematology, 14, pp. 500-503.

Madhok, R., Wu, O., McKellar, G., and Singh, G. (2006) Non-steroidal anti-inflammatory drugs—changes in prescribing may be warranted. Rheumatology, 45(12), pp. 1458-1460. (doi:10.1093/rheumatology/kel353)

Wu, O., and Langhorne, P. (2006) The challenge of acute-stroke management: does telemedicine offer a solution? International Journal of Stroke, 1(4), pp. 201-207. (doi:10.1111/j.1747-4949.2006.00062.x)

Wu, O., and Greer, I.A. (2006) More on 'universal' versus 'selected' screening for thrombophilia: the hidden costs of false-positive diagnosis - response to Favaloro and Keeling. British Journal of Haematology, 134(2), p. 241. (doi:10.1111/j.1365-2141.2006.06139.x)

Robertson, L. et al. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132(2), pp. 171-196. (doi:10.1111/j.1365-2141.2005.05847.x)

Singh, G., Wu, O., Langhorne, P., and Madhok, R. (2006) Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Research and Therapy, 8, R153. (doi:10.1186/ar2047)

Wu, O. et al. (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technology Assessment, 10, 1-+.

Wu, O. et al. (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thrombosis and Haemostasis, 94, pp. 17-25.

Wu, O. et al. (2005) Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. British Journal of Haematology, 131, pp. 80-90. (doi:10.1111/j.1365-2141.2005.05715.x)

Wu, O. (2005) Postmenopausal hormone replacement therapy and venous thromboembolism. Gender Medicine, 2(Supple), S18-S27. (doi:10.1016/S1550-8579(05)80061-0 )

Wu, O., Clark, P., Lowe, G.D.O., Walker, I.D., and Greer, I.A. (2005) Thrombophilia and venous thromboembolism after total hip or knee replacement surgery: a systematic review. Journal of Thrombosis and Haemostasis, 3(4), pp. 811-813. (doi:10.1111/j.1538-7836.2005.01264.x)

Wu, O. et al. (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombosis and Haemostasis, 94(1), pp. 17-25. (doi:10.1160/TH04-11-0759)

Robertson, L., Wu, O., and Greer, I. (2004) Thrombophilia and adverse pregnancy outcome. Current Opinion in Obstetrics and Gynecology, 16(6), pp. 453-458.

Norman, J., Wu, O., Twaddle, S., Macmillan, S., McMillan, L., Templeton, A., McKenzie, H., Noone, A., Allardyce, G., and Reid, M. (2004) An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK. BJOG: An International Journal of Obstetrics and Gynaecology, 111(11), pp. 1261-1268. (doi:10.1111/j.1471-0528.2004.00324.x)

Wu, O., Knill-Jones, R., Wilson, P., and Craig, N. (2004) The impact of economic information on medical decision making in primary care. Journal of Evaluation in Clinical Practice, 10(3), pp. 407-411. (doi:10.1111/j.1365-2753.2004.00490.x)

Norman, J., Wu, O., Twaddle, S., Macmillan, S., McMillan, L., Templeton, A., McKenzie, H., Noone, A., Allardice, G., and Reid, M. (2004) An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK. BJOG: An International Journal of Obstetrics and Gynaecology, 111(11), pp. 1261-1268. (doi:10.1111/j.1471-0528.2004.00324.x)

Book Sections

Briggs, A., Starkie, H., and Wu, O. (2009) Health economics in asthma and COPD. In: Barnes, P.J., Drazen, J.M., Rennard, S.I. and Thomson, N.C. (eds.) Asthma and COPD. Academic Press/Elsevier: London, pp. 751-760. ISBN 9780123740014

Zatarain, E., Wu, O., and Singh, G. (2006) Non-steroidal anti-inflammatory drugs-COX-2 inhibition. In: Capell, H., Luthra, H.S. and Madhok, R. (eds.) The year in rheumatic disorders. Clinical Publishing: Oxford. ISBN 9786610309962

This list was generated on Thu Mar 26 13:05:01 2015 GMT.